Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -48.67% | -68.18% | -87.94% | -95.99% | -99.61% |
Total Receivables | -- | -85.99% | 0.00% | -68.63% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -78.72% | -79.73% | -76.68% | 9.24% | 242.58% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -85.83% | -74.67% | -80.14% | -90.66% | -95.91% |
|
|||||
Total Current Assets | -85.83% | -74.67% | -80.14% | -90.66% | -95.91% |
Net Property, Plant & Equipment | -99.70% | -99.67% | -99.66% | -99.64% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -99.95% | -100.00% | -95.76% | -95.80% | -95.85% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 416.67% | 416.67% | -- |
Total Assets | -99.53% | -99.83% | -95.25% | -95.37% | -94.97% |
|
|||||
Total Accounts Payable | 74.98% | 228.91% | 128.97% | 212.80% | -53.27% |
Total Accrued Expenses | -41.49% | 653.35% | 1,716.29% | 5,481.60% | 345.21% |
Short-term Debt | 400.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 91.14% | -94.04% | -94.75% | -95.48% | -96.40% |
Total Other Current Liabilities | 91.14% | -94.04% | -94.75% | -95.48% | -96.40% |
Total Current Liabilities | 38.76% | -88.97% | -91.55% | -92.02% | -93.47% |
|
|||||
Total Current Liabilities | 38.76% | -88.97% | -91.55% | -92.02% | -93.47% |
Long-Term Debt | 15,255.56% | -- | -- | -- | -- |
Short-term Debt | 400.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 42.02% | -91.47% | -93.63% | -94.20% | -94.64% |
|
|||||
Common Stock & APIC | 18.01% | 16.45% | 16.45% | 15.83% | 0.11% |
Retained Earnings | -30.15% | -31.60% | -658.30% | -904.85% | -1,254.18% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -247.37% | -220.86% | -96.91% | -96.51% | -95.29% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | -247.37% | -220.86% | -96.91% | -96.51% | -95.29% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -246.42% | -220.24% | -96.89% | -96.49% | -95.27% |
|